BioNanomatrix has changed its name to BioNano Genomics, the company said this week.
Through the name change, the firm wants to communicate "its position as a solution provider for genomics researchers."
The company, originally based in Philadelphia but now headquartered in San Diego, has been developing a nanochannel platform, called NanoAnalyzer, to visualize single molecules of DNA. Its first applications are expected to be in de novo genome assembly and in structural variation analysis.
Earlier this year, BioNano Genomics raised $23.3 million in a Series B financing round, appointed a new president and CEO, and moved its headquarters (IS 6/21/2011).
It plans to launch the NanoAnalyzer commercially in 2012.